--- title: "Eli Lilly To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Thursday" type: "News" locale: "en" url: "https://longbridge.com/en/news/301282035.md" description: "Wall Street analysts adjusted price targets and ratings for several stocks. Cantor Fitzgerald raised Eli Lilly's target to $1,440 with an Overweight rating. Needham increased Everpure's target to $185 (Buy). Mizuho raised Delek US's target to $83 but downgraded to Neutral. Conversely, HSBC cut Constellation Brands' target to $135 (Hold), Goldman Sachs lowered Tyler Technologies' target to $345 (Neutral), HC Wainwright reduced ArriVent BioPharma's target to $27 (Buy), Morgan Stanley trimmed Netflix's target to $80 (Overweight), Baird cut Healthcare Services Group's target to $24 (Neutral), and B of A Securities lowered Levi Strauss's target to $25 (Buy)." datetime: "2026-10-08T12:58:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/301282035.md) - [en](https://longbridge.com/en/news/301282035.md) - [zh-HK](https://longbridge.com/zh-HK/news/301282035.md) generator: "portal-rs" --- # Eli Lilly To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Thursday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. - Needham raised the price target for **Everpure, Inc.** (NYSE:P) from $150 to $185. Needham analyst Matthew Calitri maintained a Buy rating. Everpure shares closed at $152.66 on Wednesday. See how other analysts view this stock. - HSBC cut **Constellation Brands, Inc**. (NYSE:STZ) price target from $192 to $135. HSBC analyst Sorabh Daga downgraded the stock from Buy to Hold. Constellation shares closed at $118.39 on Wednesday. See how other analysts view this stock. - Goldman Sachs slashed price target for **Tyler Technologies, Inc.** (NYSE:TYL) from $395 to $345. Goldman Sachs analyst Adam Hotchkiss downgraded the stock from Buy to Neutral. Tyler shares closed at $332.34 on Wednesday. See how other analysts view this stock. - HC Wainwright & Co. cut the price target for **ArriVent BioPharma, Inc.** (NASDAQ:AVBP) from $47 to $27. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. ArriVent BioPharma shares closed at $16.89 on Wednesday. See how other analysts view this stock. - Morgan Stanley cut **Netflix, Inc**. (NASDAQ:NFLX) price target from $83 to $80. Morgan Stanley analyst Sean Diffley maintained an Overweight rating. Netflix shares closed at $69.70 on Wednesday. See how other analysts view this stock. - Cantor Fitzgerald boosted **Eli Lilly and Company** (NYSE:LLY) price target from $1,410 to $1,440. Cantor Fitzgerald analyst Carter Gould maintained an Overweight rating. Eli Lilly shares closed at $1,188.72 on Wednesday. See how other analysts view this stock. - Mizuho raised **Delek US Holdings, Inc.** (NYSE:DK) price target from $66 to $83. Mizuho analyst Nitin Kumar downgraded the stock from Outperform to Neutral. Delek US Holdings shares closed at $75.46 on Wednesday. See how other analysts view this stock. - Cantor Fitzgerald increased the price target for **Amgen Inc.** (NASDAQ:AMGN) from $400 to $440. Cantor Fitzgerald analyst Carter Gould maintained a Neutral rating. Amgen shares closed at $413.08 on Wednesday. See how other analysts view this stock. - Baird cut **Healthcare Services Group Inc** NASDAQ: HCSG) price target from $26 to $24. Baird analyst Andrew Wittmann maintained a Neutral rating. Healthcare Services shares closed at $20.79 on Wednesday. See how other analysts view this stock - B of A Securities cut **Levi Strauss & Co** (NYSE:LEVI) price target from $27 to $25. B of A Securities analyst Christopher Nardone maintained a Buy rating. Levi Strauss shares closed at $19.51 on Wednesday. See how other analysts view this stock. Considering buying LLY stock? Here’s what analysts think: *Photo via Shutterstock* ### Related Stocks - [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md) - [AVBP.US](https://longbridge.com/en/quote/AVBP.US.md) - [DK.US](https://longbridge.com/en/quote/DK.US.md) - [HCSG.US](https://longbridge.com/en/quote/HCSG.US.md) - [LEVI.US](https://longbridge.com/en/quote/LEVI.US.md) - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [NFLX.US](https://longbridge.com/en/quote/NFLX.US.md) - [P.US](https://longbridge.com/en/quote/P.US.md) - [STZ.US](https://longbridge.com/en/quote/STZ.US.md) - [TYL.US](https://longbridge.com/en/quote/TYL.US.md) - [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md) - [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md) - [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md) - [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md) - [NFLP.US](https://longbridge.com/en/quote/NFLP.US.md) - [NFLU.US](https://longbridge.com/en/quote/NFLU.US.md) - [NFLW.US](https://longbridge.com/en/quote/NFLW.US.md) - [NFLY.US](https://longbridge.com/en/quote/NFLY.US.md) - [NFX.US](https://longbridge.com/en/quote/NFX.US.md) - [NFXL.US](https://longbridge.com/en/quote/NFXL.US.md) - [NFXS.US](https://longbridge.com/en/quote/NFXS.US.md) - [BAC.US](https://longbridge.com/en/quote/BAC.US.md) - [GS.US](https://longbridge.com/en/quote/GS.US.md) - [MS.US](https://longbridge.com/en/quote/MS.US.md) ## Related News & Research - [Netflix Stock (NFLX) Hit with Sell Rating in Double Down by Huber Research — Here's Why](https://longbridge.com/en/news/301736591.md) - [Netflix Stock (NFLX) Has Fallen 25% This Year. KeyBanc Sees Four Ways to Recover](https://longbridge.com/en/news/301730037.md) - [Eli Lilly reports earnings on Oct. 29. Here's why the Retatrutide story matters more than the quarter](https://longbridge.com/en/news/301730672.md) - [4,024 Eli Lilly and Company $LLY Shares Acquired by Mather Group LLC.](https://longbridge.com/en/news/301945940.md) - [Eli Lilly’s Omvoh achieves comprehensive disease control in 27.7% of ulcerative colitis patients at one year](https://longbridge.com/en/news/301975119.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**